Triad Clinical Trials

Triad Clinical Trials (TCT) was established in 2007 in Greensboro, North Carolina, and we moved into our current location, a historic 19th-century farmhouse, in 2015. At Triad Clinical Trials, our passion – and our mission – is advancing medicine through research while giving patients access to leading-edge care. The entire TCT team is dedicated to contributing to the quality and future of as many medical disciplines as possible. That’s how we have established Triad Clinical Trials as a leading multidiscipline Phase II, Phase III, and Phase IV clinical trials provided in the Triad area.

As a competent, reputable, and sought-after clinical trials resource, Triad Clinical Trials has worked on a wide range of investigations that extend across medical specialties. We work with physicians from virtually every discipline and have longstanding associations with sponsor companies, institutional review boards (IRBs), and contract research organizations (CROs).

Triad Clinical Trials also provides true multispecialty expertise. Dr. Richard M. Montgomery, medical director and principal investigator, and Dr. William “Hopp” Hopper, principal investigator, are renowned in their fields and have excellent reputations in the Triad area medical community. They have led more than 300 clinical studies combined.

These studies are FDA approved and your participation may help develop important new treatments for a number of serious medical conditions. Trial participation is completely free and your health insurance will not be charged. The Triad Clinical Trials medical team will work closely with your provider on all study-related medical matters. Trial participants are compensated for time and travel. Transportation can be provided.